Goldman Sachs Maintains Neutral on Definitive Healthcare, Raises Price Target to $3.4
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and raises the price target from $3 to $3.4.
Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and raises the price target from $3 to $3.4.